SignalCorporate
$ASND got an EMA orphan maintenance opinion for TransCon CNP in pediatric achondroplasia, keeping 10-year EU exclusivity in play. CHMP already backed approval for kids 2+ whose epiphyses are not close
$ASND got an EMA orphan maintenance opinion for TransCon CNP in pediatric achondroplasia, keeping 10-year EU exclusivity in play. CHMP already backed approval for kids 2+ whose epiphyses are not close
What changed
$ASND got an EMA orphan maintenance opinion for TransCon CNP in pediatric achondroplasia, keeping 10-year EU exclusivity in play. CHMP already backed approval for kids 2+ whose epiphyses are not close
Why it matters
$ASND got an EMA orphan maintenance opinion for TransCon CNP in pediatric achondroplasia, keeping 10-year EU exclusivity in play. CHMP already backed approval for kids 2+ whose epiphyses are not close — impact context not separately stored; see What changed.